Bevacizumab with metronomic chemotherapy of low-dose oral cyclophosphamide in recurrent cervical cancer: Four cases

• Main Authors: Rose Isono-Nakata (Author), Hiroshi Tsubamoto (Author), Tomoko Ueda (Author), Kayo Inoue (Author), Hiroaki Shibahara (Author)
• Formato: Livro
• Publicado em: Elsevier, 2018-05-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Standard chemotherapy for women with advanced or recurrent cervical cancer involves a combination of paclitaxel, platinum, and bevacizumab. However, for patients who experience anaphylaxis in response to paclitaxel or platinum, have permanent peripheral neuropathy, or develop early recurrence or pro...